9.2 C
Wednesday, May 29, 2024

Latest news: AstraZeneca

AstraZeneca admits COVID vaccine can cause ‘life-threatening’ blood clots

For the first time, AstraZeneca has admitted that its COVID vaccine can cause a deadly blood clot side effect known as Thrombosis with Thrombocytopenia Syndrome (TTS).

AstraZeneca no longer an approved COVID-19 vaccine

The Vaxzevria (AstraZeneca) is no longer an approved COVID-19 vaccine, the Australian Government Department of Health and Aged Care announced last month.

Study shows very small AstraZeneca vaccine blood clot risk

A UK study suggests a risk of blood clots after AstraZeneca's COVID-19 vaccine in about three cases per million.

EMA finds rare spinal condition, AstraZeneca vaccine link

The European Medicines Agency's safety committee says a rare spinal inflammation could be a side effect of AstraZeneca's COVID-19 vaccine.

ACT records 31 new cases, 17 infectious in the community

The ACT has recorded 31 new cases overnight, with 17 linked to existing cases or ongoing clusters and 17 in the community while infectious.

Beer and burritos for vaccinated tradies

MBA hosted a mass vaccination drive-through clinic over the weekend with over 100 tradies lining up for an AstraZeneca jab.

Oxford study finds COVID-19 vaccine efficacy wanes

A British public health study has found protection from either of the two most commonly used COVID-19 vaccines against the Delta variant of the coronavirus weakens within three months.

NSW adults can book AstraZeneca jab from Friday

Five weeks into Sydney's lockdown, NSW is opening its vaccination hubs to younger adults wanting AstraZeneca jabs.

AstraZeneca defends its vaccine for all adults

AstraZeneca has come out in defence of its vaccine for all adults after Australia's national medical panel again changed its advice for people in Sydney.

PM hails daily jabs ‘record’ amid protests

The federal government will send thousands of extra Pfizer vaccine doses to NSW to help douse Sydney's COVID-19 outbreak, as the prime minister hails a "record day" of jabs.

Under 40s still have to wait to access Pfizer

Adults under the age of 40 will still need to wait until September or October to access Pfizer vaccines.

PM isolated on changed AstraZeneca advice

Australian Medical Association president Omar Khorshid has backed medical advice that the AstraZeneca jab is not recommended for under-60s.